After the FDA’s issuance of an emergency use authorization (EUA) for the use of Covid-19 convalescent plasma (CCP), the Infectious Diseases Society of America (IDSA) and the World Health Organization (WHO) issued statements urging caution. Both organizations agreed that using CCP may hold promise as a treatment for the virus but noted a lack of hi...

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.  Evidence:Based on scientific evidence available, the FDA concluded, as outlined in its decision memorandum, this product may be effective in treating COVI...